Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: Wayne Jackson who wrote (11078)	2/12/1999 12:41:00 PM
From: Anthony@Pacific	Read Replies (1) \| Respond to of 122088

It could take 20 or 30 days as long term holders realize that their is nothing to this joke of a Company

To: Wayne Jackson who wrote (11078)	2/12/1999 12:50:00 PM
From: jjs_ynot	Respond to of 122088

Wayne, The time premium in Feb. 20 puts is too substantial given that we are essentially 4 days to expiration. If the stock stays flat; they will likely be worthless by next Weds. at the COB. March is probably a better play at this point. Or you could sell some March calls; WARNING - this is a move for an experienced option trader.

To: Wayne Jackson who wrote (11078)	2/12/1999 1:24:00 PM
From: lizard lick	Respond to of 122088

Look at CLPA and as a general point you can understand what can happen to biotecs with high expectations,, and keep in mind that clpa was in phase trials and much further ahead in trying to apply an idea to reality.. enmd is facing an extremely long road and have barely started the journey,,,, clpa was in phase trials also, enmd can barely qualify as ongoing concern yet. Others to look at MRVT Take a look at Qltif-a very nice performer, but not until they completed several phase trials years were involved and received fda approvals,, and remember on qltif sometimes they received approvals for a use they werent applying for,, or a restrictive approval, which really hurt the stock. Enmd is like looking at a kid in a sandbox saying look at me i can make diamonds out of sand ,, give me some money. Its not time and if brokers are advising clients to buy this stock at these levels and last year,, than that is where a true criminal resides.